ciprofloxacin has been researched along with cefamandole in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (28.57) | 18.7374 |
| 1990's | 2 (14.29) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 4 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Bonnet, R; Casin, I; Doublet, B; Fabre, L; Le Fleche, A; Robin, F; Weill, FX | 1 |
| Anderson, KC; Kellogg, GE; Sarkar, A | 1 |
| Grime, K; Paine, SW | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Breitenbucher, R; Guay, DR; Peterson, PK; Stein, DJ | 1 |
| Liu, C; Stratton, CW; Weeks, LS | 1 |
| Alkan, M; Berger, S; Mark, Z; Rubinstein, E; Samra, Y | 1 |
| Breitenbucher, R; Davies, S; Gruninger, R; Guay, DR; Logan, G; Obaid, S; Peterson, PK; Stein, D | 1 |
| Garcia, R; Raad, I | 1 |
| Gorman, SP; Murphy, PG; Nixon, JR; Patrick, S; Ramage, G; Tunney, MM | 1 |
| Gorman, SP; Nixon, JR; Patrick, S; Ramage, G; Tunney, MM | 1 |
1 trial(s) available for ciprofloxacin and cefamandole
| Article | Year |
|---|---|
Prospective study of lower respiratory tract infections in an extended-care nursing home program: potential role of oral ciprofloxacin.
Topics: Administration, Oral; Aged; Aged, 80 and over; Bronchitis; Cefamandole; Ciprofloxacin; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Nursing Homes; Pneumonia; Prospective Studies; Random Allocation; Respiratory Tract Infections | 1988 |
13 other study(ies) available for ciprofloxacin and cefamandole
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Molecular and biochemical characterization of the natural chromosome-encoded class A beta-lactamase from Pseudomonas luteola.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; Catheters, Indwelling; Chromosomes, Bacterial; Cloning, Molecular; Electrophoresis, Gel, Pulsed-Field; Genes, Bacterial; Genetic Variation; Isoelectric Focusing; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny; Plasmids; Pseudomonas; Pseudomonas Infections; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; Substrate Specificity | 2010 |
Computational analysis of structure-based interactions and ligand properties can predict efflux effects on antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Computational Biology; Drug Resistance, Bacterial; Hydrophobic and Hydrophilic Interactions; Ligands; Membrane Transport Proteins; Microbial Sensitivity Tests; Models, Molecular; Protein Binding; Protein Conformation; Quantitative Structure-Activity Relationship; Regression Analysis; Thermodynamics | 2012 |
Species differences in biliary clearance and possible relevance of hepatic uptake and efflux transporters involvement.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Bile; Body Weight; Dogs; Drug Administration Routes; Humans; Liver; Membrane Transport Proteins; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Organic Anion Transporters; Pharmaceutical Preparations; Protein Binding; Rats; Species Specificity | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Cost comparison of ciprofloxacin versus cefamandole.
Topics: Cefamandole; Ciprofloxacin; Costs and Cost Analysis; Delivery of Health Care; Humans; Managed Care Programs | 1989 |
Activity of LY146032 compared with that of methicillin, cefazolin, cefamandole, cefuroxime, ciprofloxacin, and vancomycin against staphylococci as determined by kill-kinetic studies.
Topics: Anti-Bacterial Agents; Cefamandole; Cefazolin; Cefuroxime; Ciprofloxacin; Culture Media; Daptomycin; Kinetics; Methicillin; Microbial Sensitivity Tests; Peptides; Staphylococcus; Staphylococcus aureus; Staphylococcus epidermidis; Vancomycin | 1987 |
In vitro activity of ciprofloxacin compared with other agents against recent hospital isolates.
Topics: Acinetobacter; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Azlocillin; Bacteria; Cefamandole; Cefotaxime; Cefsulodin; Ciprofloxacin; Citrobacter; Cloxacillin; Enterobacter; Escherichia coli; Gentamicins; Humans; Klebsiella pneumoniae; Mezlocillin; Penicillin Resistance; Proteus; Pseudomonas aeruginosa; Quinolines; Serratia marcescens; Shigella; Staphylococcus | 1986 |
In vitro study of the potential role of quinupristin/dalfopristin in the treatment of catheter-related staphylococcal infections.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Bacteremia; Catheterization, Central Venous; Cefamandole; Cephalosporins; Ciprofloxacin; Clindamycin; Daptomycin; Humans; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Neoplasms; Novobiocin; Oxacillin; Penicillins; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Teicoplanin; Vancomycin; Virginiamycin | 1996 |
Antimicrobial susceptibility of bacteria isolated from orthopedic implants following revision hip surgery.
Topics: Anti-Bacterial Agents; Arthroplasty, Replacement, Hip; Bacteria; Cefamandole; Ciprofloxacin; Erythromycin; Humans; Microbial Sensitivity Tests; Vancomycin | 1998 |
Formation of Propionibacterium acnes biofilms on orthopaedic biomaterials and their susceptibility to antimicrobials.
Topics: Alloys; Anti-Infective Agents; Bacterial Adhesion; Biocompatible Materials; Biofilms; Bone Cements; Cefamandole; Ciprofloxacin; Gentamicins; Hip Prosthesis; In Vitro Techniques; Polymethyl Methacrylate; Propionibacterium acnes; Time Factors; Titanium; Vancomycin | 2003 |